Evidence map›Paper›PMID 26590791›Full record

ArticlePsychoneuroendocrinology2016

Bi-directional effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on fear-related behavior and c-Fos expression after fear conditioning in rats.

Edward G Meloni, Archana Venkataraman, Rachel J Donahue, William A Carlezon

Abstract read
In one paragraph

Article in Psychoneuroendocrinology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. PACAP regulates neuroendocrine and behavioral stress responses via CRF-containing neurons of the rat hypothalamic paraventricular nucleus.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. A Basomedial Amygdala to Intercalated Cells Microcircuit Expressing PACAP and Its Receptor PAC1 Regulates Contextual Fear.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  16. Article
  17. Review
  18. Circulating PACAP peptide and PAC1R genotype as possible transdiagnostic biomarkers for anxiety disorders in women: a preliminary study.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Article
  19. Review
  20. PACAP induces FSHβ gene expression via EPAC.Molecular and cellular endocrinology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Edward G MeloniDepartment of Psychiatry, Harvard Medical School and McLean Hospital, Belmont, MA 02478, USA. Electronic address: emeloni@mclean.harvard.edu.
Archana VenkataramanDepartment of Psychiatry, Harvard Medical School and McLean Hospital, Belmont, MA 02478, USA.
Rachel J DonahueDepartment of Psychiatry, Harvard Medical School and McLean Hospital, Belmont, MA 02478, USA.
William A CarlezonDepartment of Psychiatry, Harvard Medical School and McLean Hospital, Belmont, MA 02478, USA.
Harvard University · US

Funding

PACAP signaling in stress and anxietyR01MH097860 · NIMH · MCLEAN HOSPITAL · PI CARLEZON, WILLIAM A. · 2013 to 2016
$1.6M
PACAP signaling in stress and anxietyR56MH097860 · NIMH · MCLEAN HOSPITAL · PI CARLEZON, WILLIAM A. · 2012 to 2012
$381k
NIMH NIH HHS MH097860NIMH NIH HHS R01 MH097860NIMH NIH HHS R56 MH097860
6 · The paper itself

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) is implicated in stress regulation and learning and memory. PACAP has neuromodulatory actions on brain structures within the limbic system that could contribute to its acute and persistent effects in animal models of stress and anxiety-like behavior. Here, male Sprague-Dawley rats were implanted with intracerebroventricular (ICV) cannula for infusion of PACAP-38 (0.5, 1, or 1.5 μg) or vehicle followed 30 min later by fear conditioning. Freezing was measured early (1, 4, and 7 days) or following a delay (7, 10, and 13 days) after conditioning. PACAP (1.5 μg) produced a bi-phasic response in freezing behavior across test days: relative to controls, PACAP-treated rats showed a reduction in freezing when tested 1 or 7 days after fear conditioning that evolved into a significant elevation in freezing by the third test session in the early, but not delayed, group. Corticosterone (CORT) levels were significantly elevated in PACAP-treated rats following fear conditioning, but not at the time of testing (Day 1). Brain c-Fos expression revealed PACAP-dependent alterations within, as well as outside of, areas typically implicated in fear conditioning. Our findings raise the possibility that PACAP disrupts fear memory consolidation by altering synaptic plasticity within neurocircuits normally responsible for encoding fear-related cues, producing a type of dissociation or peritraumatic amnesia often seen in people early after exposure to a traumatic event. However, fear memories are retained such that repeated testing and memory reactivation (e.g., re-experiencing) causes the freezing response to emerge and persist at elevated levels. PACAP systems may represent an axis on which stress and exposure to trauma converge to promote maladaptive behavioral responses characteristic of psychiatric illnesses such as post-traumatic stress disorder (PTSD).

Indexed as

Conditioning, PsychologicalAnimalsBehavior, AnimalBrainCorticosteroneDose-Response Relationship, DrugFearFreezing Reaction, CatalepticInfusions, IntraventricularMalePituitary Adenylate Cyclase-Activating PolypeptideProto-Oncogene Proteins c-fosRatsTime FactorsCorticosteronePituitary Adenylate Cyclase-Activating PolypeptideProto-Oncogene Proteins c-fosc-FosCorticosteroneFear conditioningFreezingPACAPPTSD

Identifiers

PMID26590791
PMCPMC4698186
OpenAlexW2149315740

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.